In a cross-sectional convenience sample of 1610 participants, lower levels of Aβ42 and higher ratios of p-tau 181/Aβ42 in CSF were observed among ApoE ε4 carriers compared to non-carriers in both the AD and NC groups. Here, MAPT is linked to Alzheimer disease.